Bloomberg Businessweek

Eli Lilly CEO on Submitting COVID-19 Antibody Drug to FDA

Informações:

Sinopse

Bloomberg Economics Senior U.S. Economist Yelena Shulyatyeva and Bloomberg Stocks Editor Dave Wilson discuss the latest FOMC minutes. Former Republican Strategist and Bloomberg Contributor Rick Davis provides a preview of the Vice Presidential debate. David Ricks, CEO at Eli Lilly, talks about submitting a COVID-19 antibody for FDA emergency approval. Bloomberg News Health Reporter Michelle Cortez shares a coronavirus and vaccine update. And we Drive to the Close with Rich Weiss, CIO of Multi-Asset Strategies at American Century Investments. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.